Related Experiment Videos

Stimulation of the nervous system for the management of seizures: current and future developments

Jerome V Murphy1, Arunangelo Patil

  • 1Pediatric Epilepsy Research Center, Children's Mercy Hospital, Kansas City, Missouri 64108, USA. jmurphy@cmh.edu

CNS Drugs
|January 11, 2003
PubMed

Insights

Vagal nerve stimulation (VNS) effectively reduces seizure frequency in epilepsy patients, with nearly 50% experiencing at least a 50% reduction. This therapy shows promise for various epilepsy types and other neurological conditions.

Area of Science:

  • Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Vagal nerve stimulation (VNS) emerged from the theory that altering EEG patterns could influence epilepsy.
  • Initial trials focused on refractory partial seizures in patients aged 12 and older.

Purpose of the Study:

  • To evaluate the efficacy and safety of VNS in treating refractory epilepsy.
  • To explore VNS potential in other neurological and psychiatric conditions.

Main Methods:

  • VNS implantation with generator and leads.
  • Open-label and double-blind trials.
  • Follow-up observations up to 2 years.

Main Results:

  • Nearly 50% of patients achieved ≥50% seizure frequency reduction.
  • Continued seizure control improvement observed up to 2 years.
  • Benefits extended to tuberous sclerosis complex, Lennox-Gastaut syndrome, and primary generalized seizures.

Conclusions:

  • VNS is a safe and effective adjunctive therapy for refractory epilepsy.
  • VNS may hold potential for treating depression, Alzheimer's disease, and autism.
  • Further research is needed to optimize VNS parameters and predict generator longevity.

Related Concept Videos